These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 19797536)
1. Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects. Nunes T; Almeida L; Rocha JF; Falcão A; Fernandes-Lopes C; Loureiro AI; Wright L; Vaz-da-Silva M; Soares-da-Silva P J Clin Pharmacol; 2009 Dec; 49(12):1477-82. PubMed ID: 19797536 [No Abstract] [Full Text] [Related]
2. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Almeida L; Vaz-da-Silva M; Falcão A; Soares E; Costa R; Loureiro AI; Fernandes-Lopes C; Rocha JF; Nunes T; Wright L; Soares-da-Silva P Mol Nutr Food Res; 2009 May; 53 Suppl 1():S7-15. PubMed ID: 19194969 [TBL] [Abstract][Full Text] [Related]
3. Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson's disease. Nagayama H; Ueda M; Kumagai T; Tsukamoto K; Nishiyama Y; Nishimura S; Hamamoto M; Katayama Y Parkinsonism Relat Disord; 2011 Mar; 17(3):150-2. PubMed ID: 21172738 [TBL] [Abstract][Full Text] [Related]
4. Circadian rhythmicity in levodopa pharmacokinetics in patients with Parkinson disease. Nyholm D; Lennernäs H; Johansson A; Estrada M; Aquilonius SM Clin Neuropharmacol; 2010 Jul; 33(4):181-5. PubMed ID: 20661024 [TBL] [Abstract][Full Text] [Related]
5. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
6. Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. la Porte C; Voduc N; Zhang G; Seguin I; Tardiff D; Singhal N; Cameron DW Clin Pharmacokinet; 2010 Jul; 49(7):449-54. PubMed ID: 20528005 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies. Yeh KC; August TF; Bush DF; Lasseter KC; Musson DG; Schwartz S; Smith ME; Titus DC Neurology; 1989 Nov; 39(11 Suppl 2):25-38. PubMed ID: 2685649 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and safety of resveratrol derivatives in humans after oral administration of melinjo (Gnetum gnemon L.) seed extract powder. Tani H; Hikami S; Iizuna S; Yoshimatsu M; Asama T; Ota H; Kimura Y; Tatefuji T; Hashimoto K; Higaki K J Agric Food Chem; 2014 Feb; 62(8):1999-2007. PubMed ID: 24495149 [TBL] [Abstract][Full Text] [Related]
9. Is levodopa toxic to human substantia nigra? Riley D Mov Disord; 1998 Mar; 13(2):369-70. PubMed ID: 9539360 [No Abstract] [Full Text] [Related]
10. Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease. Deleu D; Jacob P; Chand P; Sarre S; Colwell A Neurology; 2006 Sep; 67(5):897-9. PubMed ID: 16966563 [TBL] [Abstract][Full Text] [Related]
11. A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion. Westin J; Nyholm D; Pålhagen S; Willows T; Groth T; Dougherty M; Karlsson MO Clin Neuropharmacol; 2011; 34(2):61-5. PubMed ID: 21297456 [TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study. Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995 [TBL] [Abstract][Full Text] [Related]
13. Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa. Goole J; Van Gansbeke B; Pilcer G; Deleuze P; Blocklet D; Goldman S; Pandolfo M; Vanderbist F; Amighi K Int J Pharm; 2008 Nov; 364(1):54-63. PubMed ID: 18778758 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects. Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897 [TBL] [Abstract][Full Text] [Related]